Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Inventory | -6.62%607.85M | -6.18%610.93M | -23.40%650.98M | -29.88%651.15M | -16.13%849.81M | -11.77%928.64M | 4.30%1.01B | 104.43%1.05B | 321.00%971.43M | 224.67%514.86M |
| Developing and for sale properties | -8.80%19.49B | -16.48%19.68B | -33.13%21.37B | -30.00%23.57B | -23.42%31.95B | -24.59%33.67B | -19.82%41.72B | 4.33%44.65B | 41.19%52.03B | 17.13%42.8B |
| Accounts receivable | -4.88%8.58B | -20.70%7.95B | 7.46%9.02B | 22.93%10.03B | -14.41%8.39B | -17.65%8.16B | -17.49%9.81B | -2.51%9.91B | 17.57%11.89B | 29.06%10.16B |
| Related party payments receivable | -4.71%641.34M | -4.03%645.95M | 40.15%673.01M | -9.09%673.07M | -29.42%480.2M | -5.85%740.37M | -20.97%680.38M | 35.81%786.35M | 25.00%860.96M | -24.30%579.02M |
| Cash and equivalents | -67.02%68.16M | -70.14%87.17M | -21.52%206.65M | -46.17%291.91M | -63.72%263.3M | -65.78%542.33M | -94.67%725.66M | -85.35%1.59B | 73.76%13.62B | 37.71%10.82B |
| Secured deposit | -2.08%249.58M | -35.96%250.46M | -70.29%254.89M | -61.95%391.07M | -59.89%857.9M | -57.65%1.03B | -43.72%2.14B | -25.79%2.43B | -1.46%3.8B | -7.20%3.27B |
| Special items of current assets | ---- | ---- | ---- | ---- | -81.43%210.8M | ---- | --1.13B | --2.95B | ---- | ---- |
| Total current assets | -7.89%29.63B | -17.90%29.23B | -25.19%32.17B | -21.00%35.61B | -24.84%43B | -28.86%45.07B | -31.21%57.22B | -7.03%63.36B | 39.61%83.18B | 20.15%68.15B |
| Non-current assets | ||||||||||
| Property, plant and equipment | -5.43%351.31M | -5.87%361.41M | 9.13%371.49M | 5.88%383.95M | -11.33%340.42M | -8.36%362.63M | -9.86%383.9M | -9.64%395.7M | -4.62%425.91M | -3.45%437.93M |
| Investment property | -15.48%2.01B | -15.42%2.01B | -15.46%2.38B | -13.94%2.38B | -6.55%2.81B | -8.91%2.76B | -9.97%3.01B | -1.30%3.03B | 17.25%3.34B | 15.67%3.07B |
| Land use right | ---- | ---- | ---- | ---- | 7.66%32.88M | 9.24%31.69M | 3.89%30.54M | -2.29%29.01M | -10.89%29.39M | -8.67%29.69M |
| Associated company interest | -1.89%26.87M | -2.74%27.26M | -56.31%27.39M | -37.10%28.03M | -39.59%62.69M | -57.34%44.56M | -87.70%103.78M | -87.53%104.45M | 1,879.65%843.47M | 2,438.44%837.76M |
| Interests in Joint Venture | 2.73%2.98B | 0.69%2.96B | -68.12%2.9B | -68.27%2.93B | -3.41%9.11B | -0.78%9.25B | 2.54%9.43B | 14.25%9.32B | 18.62%9.2B | 7.20%8.16B |
| Intangible assets | -5.18%18.92M | -4.40%19.92M | 2.91%19.95M | 6.23%20.83M | -6.29%19.39M | -9.92%19.61M | -5.81%20.69M | 28.33%21.77M | 99.85%21.97M | 108.21%16.97M |
| Deferred tax assets | 15.76%1.03B | -3.80%1.02B | -1.05%891.81M | 15.77%1.06B | -26.76%901.28M | -29.99%918.4M | -8.98%1.23B | 12.46%1.31B | 8.04%1.35B | 18.99%1.17B |
| Special items of non-current assets | ---- | 224.66%1.88M | ---- | -98.60%580K | ---- | -10.25%41.36M | ---- | 0.75%46.08M | ---- | 2.46%45.74M |
| Total non-current assets | -2.56%6.42B | -6.02%6.4B | -50.48%6.59B | -49.30%6.81B | -6.58%13.32B | -5.84%13.43B | -6.60%14.25B | 3.61%14.26B | 22.72%15.26B | 16.47%13.77B |
| Total assets | -6.98%36.06B | -15.99%35.63B | -31.17%38.76B | -27.50%42.42B | -21.20%56.32B | -24.63%58.5B | -27.39%71.47B | -5.24%77.62B | 36.69%98.44B | 19.52%81.91B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | 17.46%19.22B | 14.76%18.3B | 47.19%16.37B | 49.28%15.95B | -7.61%11.12B | -14.83%10.68B | -48.72%12.03B | -23.73%12.54B | 47.58%23.47B | 22.73%16.44B |
| Notes payable | 572.43%14.17B | 575.97%13.5B | 244.75%2.11B | 270.18%2B | -93.18%611.18M | -93.64%539.48M | --8.96B | 149.69%8.48B | ---- | 42.73%3.4B |
| Tax payable | 14.10%4.48B | 5.70%4.23B | -0.62%3.92B | 8.28%4B | -1.16%3.95B | -3.51%3.69B | -10.05%3.99B | 0.06%3.83B | 11.78%4.44B | 18.33%3.82B |
| Amounts payable to associated parties-current liabilities | -2.12%1.94B | -6.24%1.93B | 1.81%1.99B | -2.14%2.06B | -2.13%1.95B | -1.00%2.1B | -14.98%1.99B | -51.51%2.12B | -40.10%2.34B | 24.38%4.37B |
| Bank loans and overdrafts | -0.93%7.37B | -3.43%7.43B | -28.32%7.44B | -24.21%7.7B | -4.89%10.38B | -24.51%10.15B | 68.52%10.91B | 113.97%13.45B | 21.07%6.48B | -11.32%6.29B |
| Special items of current liabilities | 6.32%898.03M | 6.07%871.55M | -9.85%844.64M | 9.11%821.69M | -40.17%936.91M | -74.02%753.11M | -45.46%1.57B | 2,164.19%2.9B | 17.19%2.87B | --128.02M |
| Total current liabilities | 29.90%57.73B | 25.56%56.09B | -0.47%44.44B | -3.79%44.67B | -30.47%44.65B | -31.96%46.43B | -2.97%64.21B | 23.21%68.24B | 37.05%66.18B | 10.03%55.39B |
| Net current assets | -129.01%-28.09B | -196.22%-26.86B | -646.32%-12.27B | -565.78%-9.07B | 76.49%-1.64B | 72.14%-1.36B | -141.14%-6.99B | -138.32%-4.89B | 50.54%17B | 100.05%12.76B |
| Total assets less current liabilities | -281.90%-21.67B | -806.16%-20.46B | -148.61%-5.67B | -118.71%-2.26B | 60.77%11.67B | 28.74%12.07B | -77.49%7.26B | -64.66%9.37B | 35.96%32.26B | 45.76%26.53B |
| Non-current liabilities | ||||||||||
| Long-term bank loan | -25.19%1.88B | -23.70%1.88B | 134.82%2.51B | 137.01%2.47B | -42.44%1.07B | -45.46%1.04B | -85.51%1.86B | -79.76%1.91B | 53.13%12.81B | 154.67%9.42B |
| Deferred tax liability | -31.08%305.69M | -33.03%310.67M | 22.51%443.53M | -3.23%463.89M | -34.39%362.04M | -26.65%479.38M | -17.62%551.83M | -14.45%653.53M | -14.22%669.83M | 35.44%763.95M |
| Convertible notes and bonds | ---- | ---- | 0.88%10.59B | 3.05%9.97B | --10.49B | --9.68B | ---- | ---- | 22.43%6.6B | 0.57%5.36B |
| Total non-current liabilities | -83.88%2.18B | -83.01%2.19B | 13.54%13.54B | 15.23%12.9B | 395.21%11.92B | 337.22%11.2B | -88.01%2.41B | -83.53%2.56B | 38.13%20.08B | 62.07%15.55B |
| Total liabilities | 3.33%59.91B | 1.23%58.28B | 2.48%57.98B | -0.09%57.57B | -15.08%56.57B | -18.61%57.63B | -22.76%66.62B | -0.18%70.81B | 37.30%86.26B | 18.36%70.93B |
| Total assets less total liabilities | -24.14%-23.85B | -49.42%-22.65B | -7,488.63%-19.21B | -1,839.00%-15.16B | -105.22%-253.18M | -87.21%871.7M | -60.16%4.85B | -37.93%6.81B | 32.53%12.18B | 27.58%10.98B |
| Total equity and non-current liabilities | -281.90%-21.67B | -806.16%-20.46B | -148.61%-5.67B | -118.71%-2.26B | 60.77%11.67B | 28.74%12.07B | -77.49%7.26B | -64.66%9.37B | 35.96%32.26B | 45.76%26.53B |
| Equity | ||||||||||
| Share capital | 0.00%175.69M | 0.00%175.69M | 0.00%175.69M | 0.00%175.69M | 0.00%175.69M | 0.00%175.69M | 0.00%175.69M | 0.00%175.69M | 0.00%175.69M | 0.00%175.69M |
| Reserve | -25.84%-23.26B | -50.81%-22.16B | -1,277.44%-18.49B | -4,370.72%-14.69B | -143.98%-1.34B | -107.65%-328.61M | -55.71%3.05B | -34.29%4.29B | 9.68%6.89B | 9.18%6.53B |
| Shareholders' Equity | -26.09%-23.09B | -51.42%-21.98B | -1,469.85%-18.31B | -9,392.52%-14.52B | -136.14%-1.17B | -103.42%-152.91M | -54.33%3.23B | -33.39%4.47B | 9.41%7.07B | 8.92%6.71B |
| Non-controlling interest | 15.45%-762.21M | -4.10%-669.88M | -198.72%-901.52M | -162.80%-643.48M | -43.78%913.24M | -56.30%1.02B | -68.23%1.62B | -45.07%2.34B | 87.20%5.11B | 74.60%4.27B |
| Total equity | -24.14%-23.85B | -49.42%-22.65B | -7,488.63%-19.21B | -1,839.00%-15.16B | -105.22%-253.18M | -87.21%871.7M | -60.16%4.85B | -37.93%6.81B | 32.53%12.18B | 27.58%10.98B |
| Total equity and total liabilities | -6.98%36.06B | -15.99%35.63B | -31.17%38.76B | -27.50%42.42B | -21.20%56.32B | -24.63%58.5B | -27.39%71.47B | -5.24%77.62B | 36.69%98.44B | 19.52%81.91B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.